Latest Earnings Results: Q3 '26
Estimated EPS
$1.88
Reported EPS
$1.90
Surprise
+1%
Estimated Rev
$2.04B
Reported Rev
$2.06B
Surprise
+1.13%
• Reported GAAP EPS of $1.90 • Reported revenue of $2.06B up 3.07% YoY • Zimmer Biomet updated full-year 2026 guidance to reported revenue change of 4.4%-4.9%, constant-currency revenue change of 4.1%-4.6%, organic constant-currency revenue change of 3.0%-3.5%, and adjusted diluted EPS of $8.50-$8.60.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $2.49 | -- | -- | N/A |
Q3 '26 | $1.88 | $1.90 | 1.00% | BEAT |
Q2 '26 | $2.01 | $2.07 | 2.97% | BEAT |
Q1 '26 | $1.87 | $2.09 | 12.05% | BEAT |
Q4 '25 | $2.40 | $2.42 | 0.92% | BEAT |